Advertisement

Topics

HAEMACURE CORPORATION Company Profile

05:30 EDT 20th September 2017 | BioPortfolio

Haemacure Corporation is a leader in the development and commercialization of innovative and clinically effective biological adhesives, biomaterials and surgical devices for a broad range of applications in the acute surgical wound care market.

Haemacure Corporation was founded in 1991 and completed its initial public offering in Canada in June 1996, raising C$28 million. Haemacure Corporation is traded under the symbol HAE on the Toronto Stock Exchange.



Haemacure’s head office is located in Montreal and it operates a wholly-owned subsidiary in Sarasota, Florida where the sales, marketing, medical and regulatory affairs offices are located.



Haemacure has devoted considerable resources to the research and development of a unique process to extract fibrinogen and thrombin from human plasma, resulting in Haemacure's fibrin sealant core technology. Fibrin sealant is a tissue glue with hemostatic, sealing and adhesive properties. It can be used in a variety of surgical procedures to arrest bleeding, seal tissues and act as an adjunct to wound healing.

Location

400 Wood Road
Braintree
MA
02184
United States of America

Contact

Phone: 514 426 7181
Fax: 514 630 7756
Email: khammes@haemacurecorp.com


News Articles [69 Associated News Articles listed on BioPortfolio]

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 ...

CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results

Achieves record reproductive health revenues on higher test volumes and average revenue per test, expands gross margin, significantly narrows operating loss and reports record cash collections Af...

NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

REHOVOT, Israel, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) diso...

Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events

MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter...

ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceuticals Corporation

RAMSEY, N.J., May 30, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) announced today that its stockholders voted to approve ADMA’s previously announced acquisition of certain asset...

International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017

CARLSBAD, Calif., May 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical st...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [170 Associated Companies listed on BioPortfolio]

HAEMACURE CORPORATION

Haemacure Corporation is a leader in the development and commercialization of innovative and clinically effective biological adhesives, biomaterials and surgical devices for a broad range of applicati...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Hot Spring Spas

Hot Spring Spas is the world’s leading brand of hot tubs and is sold through a network of more than 700 independent dealers throughout North America and 70 countries around t...

More Information about "HAEMACURE CORPORATION" on BioPortfolio

We have published hundreds of HAEMACURE CORPORATION news stories on BioPortfolio along with dozens of HAEMACURE CORPORATION Clinical Trials and PubMed Articles about HAEMACURE CORPORATION for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HAEMACURE CORPORATION Companies in our database. You can also find out about relevant HAEMACURE CORPORATION Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record